ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
887 |
348K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
887
|
348K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
272K |
12 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
978
|
272K
|
12
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
31K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
117
|
31K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
NZ Trader
|
17 |
4.9K |
4 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
17
|
4.9K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
272K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
272K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
887 |
348K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
887
|
348K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
272K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
272K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
68
|
15K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
36
|
8.0K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
21
|
6.2K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
72
|
20K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
12 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
21
|
6.2K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
21 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
21
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
21
|
6.2K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
72
|
20K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
6.0K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
22
|
6.0K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
5 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
72
|
20K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
19 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
19
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
4.0K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
15
|
4.0K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
20K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
20K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
20K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
17 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
72 |
20K |
7 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
20K
|
7
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
6.0K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
22
|
6.0K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
12 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
8 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
9 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
21
|
6.2K
|
9
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
6.0K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
22
|
6.0K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
4.0K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15
|
4.0K
|
3
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
38 |
12K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
38 |
12K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
38
|
12K
|
0
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Further Significant Improvement in Rett Syndrome Patients
|
|
NZ Trader
|
15 |
4.0K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
15
|
4.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
17K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
73
|
17K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
NZ Trader
|
68 |
15K |
31 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
68
|
15K
|
31
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
NZ Trader
|
157 |
47K |
5 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
157
|
47K
|
5
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM Commences BHP Alliances Exploration Work Programs
|
|
NZ Trader
|
38 |
12K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
38
|
12K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
NZ Trader
|
157 |
47K |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
157
|
47K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
10 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
36
|
8.0K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
8
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
8
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Proposed issue of securities - SNT
|
|
NZ Trader
|
36 |
8.0K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
36
|
8.0K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
NZ Trader
|
38 |
9.3K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
38
|
9.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notices x2
|
|
NZ Trader
|
11 |
3.8K |
12 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
11
|
3.8K
|
12
|
|